(Q46571842)

23 December 2017

title

Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report (English)

1 reference

23 December 2017

1 reference

ventricular tachycardia

1 reference

1 reference

David K Murdock

1

1 reference

23 December 2017

Jeff Kaliebe

series ordinal

2

1 reference

23 December 2017

Naomi Overton

series ordinal

3

1 reference

23 December 2017

language of work or name

1 reference

1 June 2008

1 reference

23 December 2017

Pacing and Clinical Electrophysiology

published in

1 reference

23 December 2017

volume

31

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

765-768

1 reference

23 December 2017

What causes sudden death in heart failure?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Mechanisms of ventricular arrhythmias in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Electrophysiological changes in heart failure and their relationship to arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Calcium cycling in heart failure: the arrhythmia connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Clinical pharmacokinetics of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Role of calcium cycling versus restitution in the mechanism of repolarization alternans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

Action potential duration restitution and alternans in rabbit ventricular myocytes: the key role of intracellular calcium cycling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2008.01083.X

10.1111/J.1540-8159.2008.01083.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

release_fng4u56w45gele2zmyrol6dxiq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fng4u56w45gele2zmyrol6dxiq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 December 2017